Respiri Limited (RSH.AX)
AUD 0.03
(0.0%)
AUD 0.03
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 6.19 Million AUD | 94.6% |
| 2023 | 3.18 Million AUD | -24.35% |
| 2022 | 4.2 Million AUD | -53.83% |
| 2021 | 9.1 Million AUD | 97.18% |
| 2020 | 4.61 Million AUD | 355.69% |
| 2019 | 1.01 Million AUD | -61.91% |
| 2018 | 2.66 Million AUD | 0.75% |
| 2017 | 2.64 Million AUD | -47.99% |
| 2016 | 5.07 Million AUD | -2.06% |
| 2015 | 5.18 Million AUD | -51.1% |
| 2014 | 10.6 Million AUD | 273.68% |
| 2013 | 2.83 Million AUD | -8.84% |
| 2012 | 3.11 Million AUD | -7.18% |
| 2011 | 3.35 Million AUD | -27.02% |
| 2010 | 4.59 Million AUD | -9.93% |
| 2009 | 5.1 Million AUD | -11.55% |
| 2008 | 5.76 Million AUD | 88.95% |
| 2007 | 3.05 Million AUD | 622.65% |
| 2006 | 422.38 Thousand AUD | -73.47% |
| 2005 | 1.59 Million AUD | 22.01% |
| 2004 | 1.3 Million AUD | 133.22% |
| 2003 | 559.53 Thousand AUD | -77.96% |
| 2002 | 2.53 Million AUD | -82.94% |
| 2001 | 14.87 Million AUD | 44.3% |
| 2000 | 10.31 Million AUD | -39.57% |
| 1999 | 17.06 Million AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| 1997 | - AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 6.19 Million AUD | 0.0% |
| 2024 Q2 | 6.25 Million AUD | 0.0% |
| 2024 FY | 6.19 Million AUD | 94.6% |
| 2023 FY | 3.18 Million AUD | -24.35% |
| 2023 Q2 | 3.22 Million AUD | 0.0% |
| 2023 Q4 | 3.18 Million AUD | 0.0% |
| 2022 Q2 | 6.73 Million AUD | 0.0% |
| 2022 Q4 | 4.2 Million AUD | 0.0% |
| 2022 FY | 4.2 Million AUD | -53.83% |
| 2021 FY | 9.1 Million AUD | 97.18% |
| 2021 Q2 | 12.87 Million AUD | 0.0% |
| 2021 Q4 | 9.1 Million AUD | 0.0% |
| 2020 FY | 4.61 Million AUD | 355.69% |
| 2020 Q4 | 4.61 Million AUD | 0.0% |
| 2020 Q2 | 1.3 Million AUD | 0.0% |
| 2019 Q4 | 1.01 Million AUD | 0.0% |
| 2019 FY | 1.01 Million AUD | -61.91% |
| 2019 Q2 | 3.71 Million AUD | 0.0% |
| 2018 Q4 | 2.66 Million AUD | 0.0% |
| 2018 Q2 | 1.95 Million AUD | 0.0% |
| 2018 FY | 2.66 Million AUD | 0.75% |
| 2017 Q2 | 3.23 Million AUD | 0.0% |
| 2017 Q4 | 2.64 Million AUD | 0.0% |
| 2017 FY | 2.64 Million AUD | -47.99% |
| 2016 FY | 5.07 Million AUD | -2.06% |
| 2016 Q2 | 2.6 Million AUD | 0.0% |
| 2016 Q4 | 5.07 Million AUD | 0.0% |
| 2015 Q2 | 7.61 Million AUD | 0.0% |
| 2015 FY | 5.18 Million AUD | -51.1% |
| 2015 Q4 | 5.18 Million AUD | 0.0% |
| 2014 Q4 | 10.6 Million AUD | 0.0% |
| 2014 Q2 | 12.47 Million AUD | 0.0% |
| 2014 FY | 10.6 Million AUD | 273.68% |
| 2013 Q4 | 2.83 Million AUD | 0.0% |
| 2013 FY | 2.83 Million AUD | -8.84% |
| 2013 Q1 | 5.09 Million AUD | 63.76% |
| 2013 Q2 | 5.09 Million AUD | 0.0% |
| 2013 Q3 | 2.83 Million AUD | -44.33% |
| 2012 Q4 | 3.11 Million AUD | 0.0% |
| 2012 FY | 3.11 Million AUD | -7.18% |
| 2011 FY | 3.35 Million AUD | -27.02% |
| 2011 Q4 | 3.35 Million AUD | 0.0% |
| 2010 FY | 4.59 Million AUD | -9.93% |
| 2010 Q4 | 4.59 Million AUD | 0.0% |
| 2009 FY | 5.1 Million AUD | -11.55% |
| 2009 Q4 | 5.1 Million AUD | 0.0% |
| 2008 FY | 5.76 Million AUD | 88.95% |
| 2008 Q4 | 5.76 Million AUD | 0.0% |
| 2007 Q4 | 3.05 Million AUD | 0.0% |
| 2007 FY | 3.05 Million AUD | 622.65% |
| 2006 Q4 | 422.38 Thousand AUD | 0.0% |
| 2006 FY | 422.38 Thousand AUD | -73.47% |
| 2005 FY | 1.59 Million AUD | 22.01% |
| 2005 Q4 | 1.59 Million AUD | 0.0% |
| 2004 Q4 | 1.3 Million AUD | 0.0% |
| 2004 FY | 1.3 Million AUD | 133.22% |
| 2003 FY | 559.53 Thousand AUD | -77.96% |
| 2003 Q4 | 559.53 Thousand AUD | 0.0% |
| 2002 FY | 2.53 Million AUD | -82.94% |
| 2002 Q4 | 2.53 Million AUD | 0.0% |
| 2001 Q4 | 14.87 Million AUD | 0.0% |
| 2001 FY | 14.87 Million AUD | 44.3% |
| 2000 FY | 10.31 Million AUD | -39.57% |
| 1999 FY | 17.06 Million AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1997 FY | - AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| 4DMedical Limited | 120.01 Million AUD | 94.842% |
| Adherium Limited | 9.88 Million AUD | 37.384% |
| Aroa Biosurgery Limited | 101.82 Million AUD | 93.92% |
| Atomo Diagnostics Limited | 11.37 Million AUD | 45.594% |
| Anteris Technologies Ltd | 45.7 Million AUD | 86.454% |
| Control Bionics Limited | 9.02 Million AUD | 31.42% |
| CardieX Limited | 12.64 Million AUD | 51.059% |
| Compumedics Limited | 40.35 Million AUD | 84.66% |
| Cochlear Limited | 2.74 Billion AUD | 99.774% |
| CleanSpace Holdings Limited | 26.05 Million AUD | 76.236% |
| Cyclopharm Limited | 45.91 Million AUD | 86.516% |
| EMVision Medical Devices Ltd | 23.97 Million AUD | 74.174% |
| Nova Eye Medical Limited | 29.88 Million AUD | 79.282% |
| HeraMED Limited | 2.95 Million AUD | -109.713% |
| Imricor Medical Systems, Inc. | 12.17 Million AUD | 49.155% |
| ImpediMed Limited | 46.98 Million AUD | 86.824% |
| InhaleRx Limited | 1.57 Million AUD | -292.604% |
| LBT Innovations Limited | 7.93 Million AUD | 21.94% |
| Micro-X Limited | 26.89 Million AUD | 76.981% |
| Neurotech International Limited | 12.21 Million AUD | 49.31% |
| OncoSil Medical Limited | 6.71 Million AUD | 7.851% |
| PolyNovo Limited | 109.16 Million AUD | 94.329% |
| SomnoMed Limited | 69.8 Million AUD | 91.131% |
| Universal Biosensors, Inc. | 30.12 Million AUD | 79.446% |
| Uscom Limited | 5.13 Million AUD | -20.572% |
| Visioneering Technologies, Inc. | 11.2 Million AUD | 44.751% |